Targovax ASA (GB:0RIS) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Circio Holding ASA, a biotechnology company specializing in RNA therapeutics, has announced a significant increase in its share capital to NOK 25,184,037.00, following the conversion of convertible bonds by Atlas Special Opportunities, LLC. The company is advancing its proprietary circRNA platform and developing a cancer vaccine, TG01, which is currently undergoing clinical trials in the USA and Norway.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
